Email updates

Keep up to date with the latest news and content from BMC Neuroscience and BioMed Central.

This article is part of the supplement: Proceedings of the 2007 and 2008 Drug Discovery for Neurodegeneration Conference

Open Access Email this article to a friend

Requirements for a lead compound to become a clinical candidate

Franz F Hefti

BMC Neuroscience 2008, 9(Suppl 3):S7  doi:10.1186/1471-2202-9-S3-S7

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Neuroscience's emails?